Acorah Software Products - Accounts Production 16.0.110 false true 31 July 2023 1 August 2022 false true No description of principal activity 1 August 2023 31 July 2024 31 July 2024 10862193 Mr James Zee iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10862193 2023-07-31 10862193 2024-07-31 10862193 2023-08-01 2024-07-31 10862193 frs-core:CurrentFinancialInstruments 2024-07-31 10862193 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 10862193 frs-bus:FilletedAccounts 2023-08-01 2024-07-31 10862193 frs-bus:Micro-entities 2023-08-01 2024-07-31 10862193 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 10862193 frs-bus:Director1 2023-08-01 2024-07-31 10862193 frs-bus:Director1 2023-07-31 10862193 frs-bus:Director1 2024-07-31 10862193 2022-07-31 10862193 2023-07-31 10862193 2022-08-01 2023-07-31 10862193 frs-core:CurrentFinancialInstruments 2023-07-31
Registered number: 10862193
JZ Clinical Research Consultants Ltd
Unaudited Financial Statements
For The Year Ended 31 July 2024
Wharfside Accountancy Services Limited
Balance Sheet
Registered number: 10862193
2024 2023
£ £
Current assets 145,420 143,176
Creditors: Amounts Falling Due Within One Year (146,413 ) (146,416 )
NET CURRENT LIABILITIES (993 ) (3,240 )
TOTAL ASSETS LESS CURRENT LIABILITIES (993 ) (3,240 )
NET LIABILITIES (993 ) (3,240 )
CAPITAL AND RESERVES (993 ) (3,240 )

Notes

1. General Information
JZ Clinical Research Consultants Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10862193 . The registered office is 123a Tapton Hill Road, Sheffield, South Yorkshire, S10 5GD.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 August 2023 Amounts advanced Amounts repaid Amounts written off As at 31 July 2024
£ £ £ £ £
Mr James Zee 108,014 2,245 - - 110,259
The above loan is unsecured, interest free and repayable on demand.
Page 0
Page 1
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr James Zee
Director
17/04/2025